Genocea Biosciences, Inc.
GNCADelisted Jun 2, 2022- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001457612
Genocea Biosciences, Inc. was delisted on Jun 2, 2022; its insiders filed their last Form 4 on Jun 3, 2022; 40 institutions reported holding it in 13F filings for Q1 2022, worth $42.1M in total; no superinvestor held it.
13F holders, Q2 2022
Institutional positions in Genocea Biosciences, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
GNCA is no longer listed, and 13F filings after Q1 2022 list far fewer holders. See Q1 2022
- Institutional holders
- 5
- −35 vs. Q1 2022
- Shares held
- 5.47M
- −28.2M (−83.7%) vs. Q1 2022
- Total value
- $92.0K
- −$42.0M (−99.8%) vs. Q1 2022
- New holders
- 1
- 0 more added
- Sold out
- 36
- 1 more reduced
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting GNCA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 1 | $0 |
| Q4 2025 | 1 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 1 | $0 |
| Q4 2024 | 1 | $0 |
| Q3 2024 | 1 | $1 |
| Q2 2024 | 1 | $0 |
| Q1 2024 | 1 | $0 |
| Q4 2023 | 1 | $1 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 1 | $4.00K |
| Q2 2022 | 5 | $92.0K |
| Q1 2022 | 40 | $42.1M |
| Q4 2021 | 41 | $38.9M |
| Q3 2021 | 40 | $65.3M |
| Q2 2021 | 46 | $79.4M |
| Q1 2021 | 42 | $86.3M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Genocea Biosciences, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Avoro Capital Advisors LLC | 5,084,184 | $86.0K | 0.00% | 00.0% | Unchanged |
| ABG Innovation Capital Partners III GP Ltd | 375,000 | $6.00K | 0.45% | 00.0% | Unchanged |
| Empirical Asset Management, LLC | 10,000 | $0 | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 500 | $0 | 0.00% | −8,476−94.4% | Reduced |
| Barclays PLC | 3 | $0 | 0.00% | +3 | New |
| NEA Management Company, LLC | 0 | $0 | 0.00% | −10,376,936−100.0% | Sold out |
| BVF Inc | 0 | $0 | 0.00% | −4,012,404−100.0% | Sold out |
| Commodore Capital LP | 0 | $0 | 0.00% | −3,079,756−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −2,576,385−100.0% | Sold out |
| Kingdon Capital Management, L.L.C. | 0 | $0 | 0.00% | −1,972,056−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −1,843,112−100.0% | Sold out |
| Vanguard Group Inc | 0 | $0 | 0.00% | −1,574,979−100.0% | Sold out |
| Boxer Capital, LLC | 0 | $0 | 0.00% | −1,134,453−100.0% | Sold out |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −291,733−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −215,002−100.0% | Sold out |
| HighTower Advisors, LLC | 0 | $0 | 0.00% | −212,260−100.0% | Sold out |
| Ikarian Capital, LLC | 0 | $0 | 0.00% | −206,336−100.0% | Sold out |
| BlackRock Inc. | 0 | $0 | 0.00% | −180,367−100.0% | Sold out |
| Northern Trust Corp | 0 | $0 | 0.00% | −70,837−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −57,363−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −50,517−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −42,700−100.0% | Sold out |
| Commonwealth Equity Services, LLC | 0 | $0 | 0.00% | −40,069−100.0% | Sold out |
| BIT Capital GmbH | 0 | $0 | 0.00% | −35,000−100.0% | Sold out |
| Morgan Stanley | 0 | $0 | 0.00% | −28,163−100.0% | Sold out |
| State Street Corp | 0 | $0 | 0.00% | −24,384−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −19,916−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −18,433−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −16,463−100.0% | Sold out |
| Bank of New York Mellon Corp | 0 | $0 | 0.00% | −16,305−100.0% | Sold out |
| Personal Capital Advisors Corp | 0 | $0 | 0.00% | −15,000−100.0% | Sold out |
| WealthTrust Axiom LLC | 0 | $0 | 0.00% | −15,000−100.0% | Sold out |
| Capital Asset Advisory Services LLC | 0 | $0 | 0.00% | −11,766−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −5,847−100.0% | Sold out |
| ACT Capital Management, LLC | 0 | $0 | 0.00% | −5,000−100.0% | Sold out |
| First Manhattan Co | 0 | $0 | 0.00% | −2,500−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −905−100.0% | Sold out |
| Cutler Group LP | 0 | $0 | 0.00% | −900−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −900−100.0% | Sold out |
| Artemis Wealth Advisors, LLC | 0 | $0 | 0.00% | −1,137−100.0% | Sold out |